Pembroke Pines, FL, United States of America

Wenxin Xu

This inventor holds 17 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Immunotherapy Development. Top assignees: Altor Bioscience Corporation, Nantcell, Inc., Immunitybio, Inc.. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wenxin Xu. Retrieved from https://idiyas.com/inventor/wenxin-xu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 4.4

ph-index = 6

Forward Citations = 112(Granted Patents)

Location History:

Pembroke Pines, FL (US) (2018 - 2022)
Culver City, CA (US) (2023 - 2024)

Company Filing History:

15 out of 61

Altor Bioscience Corporation

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

Areas of Expertise:

IL-15 Molecules

Neoplasia Treatment

T-cell Memory

BCG

Anti-CD20 Antibody

CTLA-4 Antibody

Immune Checkpoint Inhibitors

Multimeric Molecules

Cancer Therapy

Compositions

Methods of Use

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12491201 - Maximizing T-cell memory and compositions and methods therefor (2025-12-09),

2. 12318432 - BCG and IL-15 based molecules (2025-06-03),

3. 12268732 - IL-15-based molecules with anti-CD20 antibody and methods of use (2025-04-08),

4. 12268731 - Compositions comprising IL-15N72D-based molecules and bacillus calmette-guerin (BCG) (2025-04-08),

5. 12186372 - IL-15-based molecules and methods of treating a neoplasia (2025-01-07),

6. 12097244 - Methods of treating a neoplasia with IL-15-based molecules and CTLA-4 antibody (2024-09-24),

7. 11992516 - Compositions comprising IL-15-based molecules and immune checkpoint inhibitor antibodies (2024-05-28),

8. 11925676 - Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complex (2024-03-12),

9. 11890323 - Method of treating cancer with composition comprising IL-15-based molecules and BCG (2024-02-06),

10. 11679144 - IL-15-based molecules and methods of use thereof (2023-06-20),

11. 11471511 - IL-15-based molecules and methods of use thereof (2022-10-18),

12. 11369679 - Multimeric IL-15-based molecules (2022-06-28),

13. 11318201 - Multimeric IL-15-based molecules (2022-05-03),

14. 11229668 - Maximizing T-cell memory and compositions and methods therefor (2022-01-25),

15. 11173191 - IL-15-based molecules and methods of use thereof (2021-11-16),

Title: The Innovative Contributions of Wenxin Xu

Introduction

Wenxin Xu is a prominent inventor based in Pembroke Pines, FL (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapies for cancer and infectious diseases. With a total of 17 patents to his name, Xu's work is characterized by innovative approaches that combine various therapeutic agents.

Latest Patents

Among his latest patents, Xu has developed groundbreaking inventions such as BCG and IL-15 based molecules. This invention features combination therapies using an IL-15-based superagonist complex and an antibody to effectively treat subjects with cancer and infectious diseases. Another notable patent involves IL-15-based molecules with anti-CD20 antibody, which also focuses on combination therapies to combat cancer and infectious diseases.

Career Highlights

Wenxin Xu has worked with several notable companies in the biotechnology sector. He has been associated with Altor Bioscience Corporation and Nantcell, Inc., where he has contributed to the advancement of innovative therapies. His expertise and dedication have positioned him as a key figure in the development of effective treatment options.

Collaborations

Xu has collaborated with esteemed colleagues in his field, including Hing C Wong and Bai Liu. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in biotechnology.

Conclusion

Wenxin Xu's contributions to the field of biotechnology through his patents and collaborations highlight his commitment to advancing medical science. His innovative approaches continue to pave the way for new therapies that address critical health challenges.

Profile summary based on public USPTO records.